Ludwig Hantson
2019
In 2019, Ludwig Hantson earned a total compensation of $18.9M as Chief Executive Officer at Alexion Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,430,000 |
|---|---|
| Salary | $1,250,000 |
| Stock Awards | $15,243,634 |
| Other | $24,350 |
| Total | $18,947,984 |
Hantson received $15.2M in stock awards, accounting for 80% of the total pay in 2019.
Hantson also received $2.4M in non-equity incentive plan, $1.3M in salary and $24.4K in other compensation.
Rankings
In 2019, Ludwig Hantson's compensation ranked 179th out of 13,971 executives tracked by ExecPay. In other words, Hantson earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 179 out of 13,971 | 99th |
Division Manufacturing | 63 out of 5,701 | 99th |
Major group Chemicals And Allied Products | 17 out of 2,200 | 99th |
Industry group Drugs | 13 out of 1,886 | 99th |
Industry Pharmaceutical Preparations | 12 out of 1,398 | 99th |
Source: SEC filing on March 26, 2020.
Hantson's colleagues
We found five more compensation records of executives who worked with Ludwig Hantson at Alexion Pharmaceuticals in 2019.
2019
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2019
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research and Development
2019
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
2019
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Human Experience Officer
2019
Aradhana Sarin
Alexion Pharmaceuticals